{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT03158805","recordId":"NCT03158805","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03158805-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct03158805.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct03158805.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2017-05-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-05-16","publishedAt":"2026-08-23","recordId":"NCT03158805","recordSha256":"59a8f0b8feb6f5bde748d136ef21c14426a682337a1bb1bf804e23c6107765ad","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03158805?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2018-08-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2018-08-07","publishedAt":"2026-08-23","recordId":"NCT03158805","recordSha256":"acb2f85f8b51f3cc7899758ed85fcc04669520a98efb402e57d97c51ce9576da","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03158805?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2019-03-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-03-25","publishedAt":"2026-08-23","recordId":"NCT03158805","recordSha256":"27cc490297f77c983e9fe84e4202afc5ada6f48afe4a4865d2d746224ce75a17","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03158805?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2020-08-31","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2020-08-31","publishedAt":"2026-08-23","recordId":"NCT03158805","recordSha256":"e0f82372d4543d84f45beeca6481247d28bb6fae942c535da7ff0612626c8160","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03158805?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2022-05-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-05-24","publishedAt":"2026-08-23","recordId":"NCT03158805","recordSha256":"d36e6f7f2b038209fc6e6fe031fb9a302d1054026b3d4ec9e1bb25d3a6e66b89","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03158805?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2023-03-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2023-03-07","publishedAt":"2026-08-23","recordId":"NCT03158805","recordSha256":"d5ee512d3565ccca73d647ac52855f036bb7bdc7a48edb34bcb1815d4ef0a3e6","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03158805?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2023-10-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2023-10-05","publishedAt":"2026-08-23","recordId":"NCT03158805","recordSha256":"0b98e8e1c50d99024c0abe301e0e5674d68ff7089b8f3dd89d5523636e2a853a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03158805?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Baseline Characteristics","Outcome Measures (Results)","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2024-03-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2024-03-01","publishedAt":"2026-08-23","recordId":"NCT03158805","recordSha256":"7e0e8a4feacfe6ec7d3c01870b3c3ae67d3c5665c5d25c25b24fad7654f77ffe","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03158805?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Limitations and Caveats","Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2025-03-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2025-03-03","publishedAt":"2026-08-23","recordId":"NCT03158805","recordSha256":"c485ca22c441451ceb2b497cc2c1a4395c104d5662280f1578fe7ea7aff340f7","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03158805?a=11&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"d49f759f5e0bbf1df4689c995f6822f3fe8d35193547de76ffc0411373743fec"}}